↓ Skip to main content

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, December 2017
Altmetric Badge

Mentioned by

reddit
1 Redditor

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
46 Mendeley